This inventor holds 1 USPTO granted patent. Top assignee: Acorda Therapeutics, Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Kathryn L McCabe: Innovator in Eye Treatment Technologies
Introduction
Kathryn L McCabe is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of ophthalmology. She has developed innovative methods aimed at treating disorders of the eye, particularly focusing on the function of retinal cells.
Latest Patents
Kathryn holds a patent for "Methods of treating disorders of the eye." This invention provides methods for promoting the function of retinal cells using neuregulins. A novel aspect of her work involves the use of neuregulins as growth factors to promote the survival of retinal cells. The treatments she has developed may slow or halt net cell loss or increase the amount or quality of retinal tissue present in vertebrates.
Career Highlights
Kathryn is associated with Acorda Therapeutics, Inc., where she continues to advance her research and innovations in eye treatment technologies. Her work has the potential to significantly impact the lives of individuals suffering from retinal disorders.
Collaborations
Some of her notable coworkers include Thomas A Reh and Mark Andrew Marchionni, who contribute to her research efforts and innovations in the field.
Conclusion
Kathryn L McCabe's work exemplifies the intersection of innovation and healthcare, particularly in the treatment of eye disorders. Her contributions are paving the way for new therapeutic approaches that could enhance the quality of life for many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile